Hopkins Marianne R, Ettinger Adrienne S, Hernández-Avila Mauricio, Schwartz Joel, Téllez-Rojo Martha María, Lamadrid-Figueroa Héctor, Bellinger David, Hu Howard, Wright Robert O
Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, USA.
Environ Health Perspect. 2008 Sep;116(9):1261-6. doi: 10.1289/ehp.11233.
Given the association between iron deficiency and lead absorption, we hypothesized that variants in iron metabolism genes would predict higher blood lead levels in young children.
We examined the association between common missense variants in the hemochromatosis (HFE) and transferrin (TF) genes and blood lead levels in 422 Mexican children.
Archived umbilical cord blood samples were genotyped for HFE (H63D and C282Y) and TF (P570S) variants. Blood lead was measured at 24, 30, 36, 42, and 48 months of age. A total of 341 subjects had at least one follow-up blood lead level available and data available on covariates of interest for inclusion in the longitudinal analyses. We used random-effects models to examine the associations between genotype (HFE, TF, and combined HFE + TF) and repeated measures of blood lead, adjusting for maternal blood lead at delivery and child's concurrent anemia status.
Of 422 children genotyped, 17.7, 3.3, and 18.9% carried the HFE H63D, HFE C282Y, and TF P570S variants, respectively. One percent of children carried both the HFE C282Y and TF P570S variants, and 3% of children carried both the HFE H63D and TF P570S variants. On average, carriers of either the HFE (beta = 0.11, p = 0.04) or TF (beta = 0.10, p = 0.08) variant had blood lead levels that were 11% and 10% higher, respectively, than wild-type subjects. In models examining the dose effect, subjects carrying both variants (beta = 0.41, p = 0.006) had blood lead 50% higher than wild-type subjects and a significantly higher odds of having a blood lead level > 10 microg/dL (odds ratio = 18.3; 95% confidence interval, 1.9-177.1).
Iron metabolism gene variants modify lead metabolism such that HFE variants are associated with increased blood lead levels in young children. The joint presence of variant alleles in the HFE and TF genes showed the greatest effect, suggesting a gene-by-gene-by-environment interaction.
鉴于缺铁与铅吸收之间的关联,我们推测铁代谢基因的变异可预测幼儿的血铅水平更高。
我们研究了血色素沉着症(HFE)基因和转铁蛋白(TF)基因的常见错义变异与422名墨西哥儿童血铅水平之间的关联。
对存档的脐带血样本进行HFE(H63D和C282Y)和TF(P570S)变异的基因分型。在儿童24、30、36、42和48月龄时测量血铅水平。共有341名受试者至少有一次随访血铅水平数据,且有关于纳入纵向分析的相关协变量的数据。我们使用随机效应模型来研究基因型(HFE、TF以及联合的HFE + TF)与血铅重复测量值之间的关联,并对分娩时母亲的血铅水平和儿童同时存在的贫血状态进行校正。
在422名进行基因分型的儿童中,分别有17.7%、3.3%和18.9%携带HFE H63D、HFE C282Y和TF P570S变异。1%的儿童同时携带HFE C282Y和TF P570S变异,3%的儿童同时携带HFE H63D和TF P570S变异。平均而言,携带HFE变异(β = 0.11,p = 0.04)或TF变异(β = 0.10,p = 0.08)的儿童血铅水平分别比野生型受试者高11%和10%。在研究剂量效应的模型中,同时携带两种变异的受试者(β = 0.41,p = 0.006)血铅水平比野生型受试者高50%,且血铅水平>10μg/dL的几率显著更高(优势比 = 18.3;95%置信区间,1.9 - 177.1)。
铁代谢基因变异会改变铅代谢,使得HFE变异与幼儿血铅水平升高有关。HFE和TF基因中变异等位基因的共同存在显示出最大的影响,提示基因 - 基因 - 环境相互作用。